GR 127607
Latest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antimigraines
- Mechanism of Action 5-HT1 serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 24 Aug 1999 Discontinued-I for Migraine in United Kingdom (Unknown route)
- 03 Feb 1997 No-Development-Reported for Migraine in United Kingdom (Unknown route)